Cronos Group Inc. (NASDAQ:CRON) Q3 2023 Earnings Call Transcript

Page 3 of 3

So I think medical, you’re almost always likely going to have a better margin profile than in more developed adult-use market. And we haven’t really seen anything that reverses that trend. So whether it’s Israel, Germany, Australia, we still see a lot of positives overall from flower.

Operator: Thank you. I’m showing no further questions at this time. Ladies and gentlemen, this does conclude today’s conference. Thank you all for participating. You may now disconnect. Have a great day.

Follow Cronos Group Inc. (NASDAQ:CRON)

Page 3 of 3